ARCHIVES

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Ozols Promoted At Fox Chase; Greenberger Moves To Pittsburgh; ACR Names New Officers

October 8, 1993

Proposed Criteria For Establishing Carcinogenicity Listed

November 21, 1975

In Brief: DeVita Vs. Lincoln; ACS Says It Will Take “New Initiatives In Political Forums”

March 17, 1978

WHI Update: No Increased Risk Of Cancer With Estrogen-Alone

April 28, 2006

NCAB Supports ACS Effort To Work With Centers

March 1, 1991

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001